Modifi
Category
Articles about Modifi:
- January 10, 2025 Weekly funding round-up! All of the European startup funding rounds we tracked this week (Jan 6 – Jan 10)
- December 17, 2024 The role of real-world evidence in accelerating drug development
- November 15, 2024 Weekly funding round-up! All of the European startup funding rounds we tracked this week (Nov 11 – Nov 15)
- November 8, 2024 Weekly funding round-up! All of the European startup funding rounds we tracked this week (Nov 4 – Nov 8)
- October 24, 2024 Taking the Next Bite into the future: EIT Food announces new innovation opportunities (Sponsored)
- September 16, 2024 Paris-based startup Samp raises €6 million to speed up deployment of digital twin solution
- July 31, 2024 From labs to market: 10 promising biotech startups based in the UK
- July 29, 2024 EIT Health Catapult finalist “Pan Cancer T” closes a €4 million seed extension funding round (Sponsored)
- July 26, 2024 London-based Fractile exits stealth with €13.8 million seed to develop radical new AI chip
- April 25, 2024 Berlin-based goodcarbon secures €5.25 million to bring new high-quality nature-based solutions to market
- April 22, 2024 Paris-based Payflows raises €25 million Series A to build the command centre for finance teams
- April 10, 2024 The Surge of On Device Fraud (ODF) in 2024 and why you should care about it
- December 19, 2023 London-based Imaginario AI secures €900k pre-seed to bring the power of AI to video content
- December 5, 2023 Paris-based Eligo Bioscience raises €27.7 million Series B to to create a novel class of transformative genetic medicines
- November 29, 2023 Introducing Orgavalue – The 2023 EIT InnoStars Awards winner
- November 17, 2023 Weekly funding round-up! All of the European startup funding rounds we tracked this week (November 13 – November 17 )
- July 21, 2023 Weekly funding round-up! All of the European startup funding rounds we tracked this week (July 17-21)
- July 3, 2023 Paris-based Exeliom Biosciences completes final close of €24 million Series A to further progress its microbiome-based inmunotherapy